Recombinant multi-species STAG3L5P-PVRIG2P-PILRB/ FDFACT/ LOC101735302-LOC101752334-PILRB protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine STAG3L5P-PVRIG2P-PILRB protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The target: STAG3L5P-PVRIG2P-PILRB, gene name: STAG3L5P-PVRIG2P-PILRB, also named as FDFACT, LOC101735302-LOC101752334-PILRB, PILRB. This locus represents naturally occurring readthrough transcription among the neighboring LOC101735302 (stromal antigen 3 pseudogene), LOC101752334 (poliovirus receptor related immunoglobulin domain containing pseudogene) and PILRB (paired immunoglobin-like type 2 receptor beta) genes on chromosome 7. The readthrough transcript is a candidate for nonsense-mediated mRNA decay (NMD), and is unlikely to produce a protein product. [provided by RefSeq, Jun 2013].
Order information
* GeneMedi provides NON-PROFIT PRICE to support Academic research.Please click inquiry for product quotation. → Inquiry
Catalog No. | Product Name | Species | Size | Price |
GM-Tg-hg-IP1838-Ag-1 | Human STAG3L5P-PVRIG2P-PILRB protein | Human | 1mg/10mg/100mg/≥100mg | Inquiry |
GM-Tg-rg-IP1838-Ag-1 | Rat STAG3L5P-PVRIG2P-PILRB protein | Rat | 1mg/10mg/100mg/≥100mg | Inquiry |
GM-Tg-mg-IP1838-Ag-1 | Mouse STAG3L5P-PVRIG2P-PILRB protein | Mouse | 1mg/10mg/100mg/≥100mg | Inquiry |
GM-Tg-cynog-IP1838-Ag-1 | Cynomolgus/ Rhesus macaque STAG3L5P-PVRIG2P-PILRB protein | Cynomolgus/ Rhesus macaque | 1mg/10mg/100mg/≥100mg | Inquiry |
GM-Tg-felg-IP1838-Ag-1 | Feline STAG3L5P-PVRIG2P-PILRB protein | Feline | 1mg/10mg/100mg/≥100mg | Inquiry |
GM-Tg-cang-IP1838-Ag-1 | Canine STAG3L5P-PVRIG2P-PILRB protein | Canine | 1mg/10mg/100mg/≥100mg | Inquiry |
GM-Tg-bovg-IP1838-Ag-1 | Bovine STAG3L5P-PVRIG2P-PILRB protein | Bovine | 1mg/10mg/100mg/≥100mg | Inquiry |
GM-Tg-bovg-IP1838-Ag-1 | Equine STAG3L5P-PVRIG2P-PILRB protein | Equine | 1mg/10mg/100mg/≥100mg | Inquiry |
Shipping Cost: | 760.00 |
Description
Catalog No. | GM-Tg-hg-IP1838-Ag, GM-Tg-rg-IP1838-Ag, GM-Tg-mg-IP1838-Ag, GM-Tg-cynog-IP1838-Ag, GM-Tg-felg-IP1838-Ag, GM-Tg-cang-IP1838-Ag, GM-Tg-bovg-IP1838-Ag, GM-Tg-equg-IP1838-Ag-1 |
Products Name | STAG3L5P-PVRIG2P-PILRB protein |
Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
Target Name | STAG3L5P-PVRIG2P-PILRB |
Protein Sub-location | Introcelluar Protein |
Isotypes | Recombinant protein |
Expression platform | Mammalian cell |
Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
Tag | His |
Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine STAG3L5P-PVRIG2P-PILRB protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
- GENEMEDI
- Email: [email protected] [email protected]
- Telephone: +86-21-50478399 Fax: 86-21-50478399
- Privacy Policy
- TECHNICAL SUPPORT
- Product FAQs
- Technical manuals
- Publications
- Email: [email protected]

